logo
Select company
Select metric
17.41%Capital Expenditures Margin
VS
Market
15
Sector
14
Industry
26
History
64
$ 6.42Close
$ 1.06 - $ 6.45 52-Week Range
Ticker Information

Ticker

ATAI

Company Name

ATAI LIFE SCIENCES NV

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

ATAI LIFE SCIENCES NV - Capital Expenditures Margin Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

ATAI - CapEx % Historical data
DateCapital ExpenditureCapital Expenditures MarginRevenues
6/30/2025$ 402K17.41%$ 2.31M
3/31/2025$ 275K14.76%$ 1.86M
12/31/2024$ 12K3.9%$ 308K
9/30/2024$ 23K6.95%$ 331K
6/30/2024$ 24K6.35%$ 378K
3/31/2024$ 152K54.87%$ 277K
12/31/2023$ 590K187.9%$ 314K
9/30/2023$ 796K238.32%$ 334K
6/30/2023$ 1.32M488.19%$ 271K
3/31/2023$ 1.41M524.54%$ 269K
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • ATAI LIFE SCIENCES NV's latest trailing twelve months (TTM) CapEx % stands at 0%.
  • Over the past 5 years, ATAI LIFE SCIENCES NV's average CapEx % has been 167.55%.
  • The median CapEx % for ATAI LIFE SCIENCES NV during this period was 112.91%
  • ATAI LIFE SCIENCES NV reached its highest CapEx % over the past 5 years at 524.54%.
  • The lowest CapEx % recorded by ATAI LIFE SCIENCES NV in the same timeframe 3.9%

ATAI LIFE SCIENCES NV's CapEx % vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

CapEx % Benchmarks
CompanyCapEx %
UPB : UPSTREAM BIO INC 20.49%KALV : KALVISTA PHARMACEUTICALS INC 89.83%VSTM : VERASTEM INC -CNTB : CONNECT BIOPHARMA HOLDINGS LTD 35.42%INBX : INHIBRX BIOSCIENCES INC 20.29%PROK : PROKIDNEY CORP 6102.47%SION : SIONNA THERAPEUTICS INC -NTRB : NUTRIBAND INC 2.03%ORMP : ORAMED PHARMACEUTICALS INC 98.6%TRVI : TREVI THERAPEUTICS INC -

Definition of Capital Expenditures Margin

[Calculation] The CapEx Margin, also named Capex to Revenue Ratio, measures how much of a company’s revenue is reinvested into productive [Assets]. It is capital expenditures [CapEx] divided by [Revenue].
CapEx / Revenues
(=) CapEx %
CapEx % for ATAI LIFE SCIENCES NV is calculated as follows: CapEx [ $ 59K ] / Revenues [ $ 0 ]
(=) CapEx % [ 0% ]

ATAI - Capital Expenditures Margin, Last 5 years

3.9%

Minimum

Dec 31, 2024

524.54%

Maximum

Mar 31, 2023

167.55%

Average

112.91%

Median

CapEx % Benchmark Analysis

The chart above depicts the distribution of CapEx % for companies in the Total Stock Market. The average CapEx % of the companies is 3.46% with a standard deviation of 3.27%.
The following table provides additional summary stats:
CapEx % in the Market:
filtered constituents2.85K
min0%
max15.04%
average3.46%
median2.43%
std3.27%